Dr Lurmag Y Orta Gonzalez, MD | |
Po Box 1996, Trujillo Alto, PR 00977-1996 | |
(787) 787-9481 | |
(787) 787-9533 |
Full Name | Dr Lurmag Y Orta Gonzalez |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology |
Location | Po Box 1996, Trujillo Alto, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508014622 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0101X | Pathology - Anatomic Pathology | 17268 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lurmag Y Orta Gonzalez, MD Route 181, Lago Alto Plz, Trujillo Alto, PR 00976 Ph: (787) 305-5200 | Dr Lurmag Y Orta Gonzalez, MD Po Box 1996, Trujillo Alto, PR 00977-1996 Ph: (787) 787-9481 |
News Archive
Diamyd completed screening for US Phase III study in type 1 diabetes. The screening of patients for the US Phase III study, DiaPrevent, was completed, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age had, at the completion of screening, been enrolled in the study and received their first injection of the antigen-based therapy Diamyd® or placebo.
The Oklahoma attorney general argued that the Internal Revenue Service does not have the power to implement the health overhaul.
Sciele Pharma, Inc., a Shionogi company, today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders.
A disposable cup – favoured by many of the high street's well known coffee shops – is the inspiration behind a new and scientifically reviewed device for the safe and prompt treatment of school age children suffering acute asthma, which often presents as an emergency situation.
Scientists from the Florida campus of The Scripps Research Institute have produced an approach that protects animal models against a type of genetic disruption that causes intellectual disability, including serious memory impairments and altered anxiety levels.
› Verified 9 days ago